Safe Orthopaedics s’introduit sur Euronext

Raises €9.6 million with market capitalisation of €33 million

Paris – 10 February 2015 – EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs^[1], today announced the listing of Safe Orthopaedics, a French medical technology company, in Compartment C of the Euronext Paris regulated market.

Founded in 2010, Safe Orthopaedics develops and markets an innovative range of sterile implants and associated single-use surgical instruments, designed to optimise spinal surgery and make it safer and less costly. By eliminating the reuse of surgical instruments, Safe Orthopaedics reduces the risk of infection, avoids the cumbersome, unreliable logistics of instrument sterilisation, and limits hospital costs.

Safe Orthopaedics (ticker code: SAFOR) was listed through the admission to trading of the 12,937,903 ordinaryshares making up its equity, including 3,750,641new shares issued under a Global Offering^[2].

The admission and issue price of Safe Orthopaedics shares was set at €2.55 per share. Market capitalisation was €33 million on the day of listing, and the transaction raised a total of €9.6 million.

Yves Vignancour, CEO of Safe Orthopaedics said: “Our listing on Euronext is a key stage in stepping up the pace of our product innovation and international growth. We would like to thank our existing shareholders, as well as all those who have joined us now, for their trust and support in making spinal surgery safer and more effective.”

Eric Forest, Chairman and CEO of EnterNext said: “We congratulate Safe Orthopaedics, an innovative spinal surgery specialist, on its listing on Euronext—a move that brings it into the dynamic 66-member family of life science businesses listed on Euronext markets. This operation will enable the company to support and accelerate deployment of its innovative and ambitious strategy on global markets.”

_{^[1]Small and medium-size companies^[2]The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries}

Press Release Footer

About Euronext
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With nearly 1,900 listed issuers and around €6.3 trillion in market capitalisation as of end September 2024, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

_Disclaimer
_{This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.}

_{This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at}_{www.euronext.com/terms-use}_.